What is the issue size of Saroja Pharma IPO?

The issue size of the Saroja Pharma IPO is Rs 9.11 cr.

What is 'pre-apply' for Saroja Pharma IPO?

Pre-apply will alow you to apply for the Saroja Pharma IPO 2 days before the subscription period starts.

If I pre-apply for Saroja Pharma IPO, when will my order get placed?

Your order will be placed on the exchange as soon as the Saroja Pharma IPO bidding starts. You will receive a UPI request within 24 hours after the bidding period opens.

When will I know if my Saroja Pharma IPO order is placed?

We will notify you when your Saroja Pharma IPO order is placed with the exchange.

What are the open and close dates of the for Saroja Pharma IPO?

Saroja Pharma IPO will be open between 31 August - 5 Sept, 2023.

What is the lot size and minimum order quantity of the Saroja Pharma IPO?

Saroja Pharma Limited IPO lot size is 1600 shares.

What are the allotment dates for the Saroja Pharma IPO?

Saroja Pharma IPO allotment date is 8 Sept, 2023. For Saroja Pharma IPO allotment status check, you can visit the website of the registrar of the IPO.

Who is the registrar of Saroja Pharma IPO?

Saroja Pharma IPO registrar is Kfin Technologies Limited. You can check Saroja Pharma IPO allotment status on the website of the registrar.

Where is the Saroja Pharma IPO getting listed?

The shares are proposed to be listed on NSE SME.

Saroja Pharma SME IPO

Saroja Pharma Limited

₹1,34,400 /1600 sharesMinimum Investment

Saroja Pharma SME IPO Listing DetailsListed OnIssue PriceListing PriceListing Gains
NSE₹84.00₹65.00-₹19.00 (22.62%)
Saroja Pharma SME IPO DetailsBidding DatesMin. InvestmentLot SizePrice Range
31 Aug ‘23 - 5 Sep ‘23₹1,34,4001,600₹84 - ₹84
Issue SizeIPO Doc
9.11CrRHP PDF
About Saroja Pharma SMESaroja Pharma, founded in 2019, is engaged in the trade of active pharmaceutical ingredients, specialty chemicals, and pharma intermediates. The company is actively involved in importing and exporting specialty chemicals, catering to the specific needs of its clients in India and overseas. Saroj Pharma specializes in customizing specialty chemicals for various applications in industries such as pharmaceuticals, agriculture, and chemicals, serving both human and veterinary sectors.;
Parent Organisation
Saroja Pharma Limited
Founded
2019
Managing Director
Mr. Biju Gopinathan Nair
Strengths & Risks
Saroj Pharma has a diverse product range, including pharmaceuticals, pharma API, and pharma intermediates. They supply various products, such as Liquid Bromine, which is an Agro Intermediate, and Ethyl Acetate, which is used as an API solvent for agro intermediates. 
Additionally, the company offers medications for both human and veterinary use, some of which serve as API solvents.
The company's reach extends across different regions, with a notable presence in both Indian and international markets. They have successfully exported their products to countries such as Pakistan, Egypt, Russia, Jordan, Hong Kong, and Singapore.
The company maintains a broad spectrum of brands within the pharmaceutical industry, covering various therapeutic areas. They also offer specialty and performance-enhancing products in the chemical industry.
Saroj Pharma relies heavily on its top customers. Its top 10 customers generated 83.51%, 68.92%, and 74.53% of operating revenue as of March 31 in 2023, 2022, and 2021, respectively. Losing major customers could severely impact the company's business.
The company's domestic sales are closely tied to the top 5 states in India. These states, including Andhra Pradesh, Gujarat, Maharashtra, Telangana, and Tamil Nadu, contributed nearly 89.67%, 77.29%, and 82.65% of its total revenue as of March 31 in 2023, 2022, and 2021, respectively.
The company's reliance on a limited number of suppliers poses another risk. The top 10 suppliers account for 62.86%, 68.15%, and 73.58% of their total purchases for the years ending on March 31 in 2023, 2022, and 2021, respectively. 
The company handles hazardous materials and accidents involving these substances could result in liability for damages and legal proceedings.
The company has experienced negative cash flow in recent years.
The company relies on third-party transportation providers to deliver goods to and from suppliers and clients. Any failure by these service providers to meet their obligations could significantly impact the company's business.
Financials
*All values are in Rs. Cr
No Graph Data To Display
Application detailsApply asPrice bandApply upto
Regular₹84 - 84₹2 Lakh
High Networth Individual₹84 - 84₹2 - 5 Lakh
For Saroja Pharma SME IPO, eligible investors can apply as Regular.

Listed On	Issue Price	Listing Price	Listing Gains
NSE	₹84.00	₹65.00	-₹19.00 (22.62%)

Bidding Dates	Min. Investment	Lot Size	Price Range
31 Aug ‘23 - 5 Sep ‘23	₹1,34,400	1,600	₹84 - ₹84

Issue Size	IPO Doc
9.11Cr	RHP PDF

Apply as	Price band	Apply upto
Regular	₹84 - 84	₹2 Lakh
High Networth Individual	₹84 - 84	₹2 - 5 Lakh

Vaishnavi Tech Park, 3rd & 4th Floor
Sarjapur Main Road, Bellandur
Bengaluru – 560103
Contact Us
PRODUCTS
StocksFutures & OptionsIPOMutual FundsCreditBill Payments
GROWW
About UsPricingBlogMedia & PressCareersHelp and Support
QUICK LINKS
AMC Mutual FundsCalculatorsGlossaryOpen Demat AccountGroww DigestSitemap
ⓒ 2016-2023 Groww. All rights reserved, Built with ♥in India

ABOUT GROWW

Groww is India’s growing financial services platform where users can find their investment solutions pertaining to mutual funds, stocks, US Stocks, ETFs, IPO, and F&Os, to invest their money without hassles.

Groww objectively evaluates stocks and mutual funds and does not advise or recommend any stocks, mutual funds or portfolios. Investors shall invest at their own discretion, will and consent. Groww, at any time, does not guarantee fixed returns on the capital invested.

Groww helps investors -

· By providing 100% paperless online free Demat and trading account opening

· By providing an objective evaluation of products available on the platform

· By being transparent about fees and charges involved while investing in a product

· By offering decision-making assistance by providing technical analysis with advanced charts, well-designed line & candlestick charts that indicate share price movements, and market indices, along with more details about all registered and listed companies

SECURE TRANSACTIONS ON GROWW

All transactions on Groww are safe and secure. Users can invest through SIP or Lumpsum using Netbanking through all supported banks. It uses BSE Star MF (with Member code 11724) as transaction platform.

TRADE AND INVEST SECURELY WITH GROWW

Stocks, Mutual fund investments, F&Os, etc., are very popular with individual investors because of their numerous benefits. On Groww, an investor can -

- Invest in Nifty 50 (NSE) & Sensex (BSE) listed stocks

- Diversify across multiple stocks and other instruments

- Start SIP with any amount (as low as Rs. 500)

- Switch regular funds to direct funds

- Start automated monthly investments (SIP), and benefit from many more features

All type of mutual funds are available on Groww.

INVESTING IN MUTUAL FUND PORTFOLIOS

Portfolio is collection of mutual funds designed to meet your investment goals. Investing in mutual fund portfolios helps you in diversifying your investments and reduces the risk. Portfolios also help you in assigning an investment goals and make it easy for you to save for and achieve your goals. You can create a portfolio yourself or ask an expert to build it for you.

ATTENTION INVESTORS

1. For Stock Broking Transaction 'Prevent unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day...Issued in the interest of Investors.

2. For Depository Transaction 'Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL/NSDL on the same day...Issued in the interest of investors.

3. KYC is a one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

4. If you are subscribing to an IPO, there is no need to issue a cheque. Please write the Bank account number and sign the IPO application form to authorize your bank to make payment in case of allotment. In case of non allotment the funds will remain in your bank account.

· Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website.

· Awareness regarding guidelines on Margin collection

1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

3. Pay 20% upfront margin of the transaction value to trade in cash market segment.

4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.

Issued in the interest of Investors

DISCLAIMER

NextBillion Technology Private Limited (CIN: U65100KA2016PTC092879) is a member of NSE & BSE with SEBI Registration no: INZ000301838, Depository Participant of CDSL Depository with SEBI Registration no: IN-DP-417-2019 and Mutual Fund distributor with AMFI Registration No: ARN-111686. Registered office and Correspondence office - No.11, 2nd floor, 80 FT Road, 4th Block, S.T Bed, Koramangala, Bengaluru – 560034. For any grievances related to Stock Broking/DP, please write to [email protected] , please ensure you carefully read the Risk Disclosure Document as prescribed by SEBI.

Procedure to file a complaint on SEBI SCORES: Register on the SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.

NextBillion Technology Private Limited makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Unless otherwise specified, all returns, expense ratio, NAV, etc are historical and for illustrative purposes only. Future will vary greatly and depends on personal and market circumstances. The information provided by our blog is educational only and is not investment or tax advice.

Mutual fund investments are subject to market risks. Please read all scheme related documents carefully before investing. Past performance of the schemes is neither an indicator nor a guarantee of future performance.

Terms and conditions of the website/app are applicable. Privacy policy of the website is applicable.